Net Income (Loss) Attributable to Parent in USD of Instil Bio, Inc. from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Instil Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2020 to Q3 2025.
  • Instil Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$13.6M, a 41% increase year-over-year.
  • Instil Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$75.1M, a 0.12% increase year-over-year.
  • Instil Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$74.1M, a 52.5% increase from 2023.
  • Instil Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$156M, a 30.1% increase from 2022.
  • Instil Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$223M, a 42.3% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Instil Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$75.1M -$13.6M +$9.43M +41% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$84.5M -$21.4M -$6.48M -43.4% 01 Apr 2025 30 Jun 2025 10-Q 13 Nov 2025
Q1 2025 -$78M -$28.2M -$3.9M -16% 01 Jan 2025 31 Mar 2025 10-Q 13 Nov 2025
Q4 2024 -$74.1M -$11.9M +$1.03M +7.97% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025
Q3 2024 -$75.2M -$23M +$44.4M +65.9% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$120M -$14.9M +$3.75M +20.1% 01 Apr 2024 30 Jun 2024 10-Q 13 Nov 2025
Q1 2024 -$123M -$24.3M +$32.8M +57.4% 01 Jan 2024 31 Mar 2024 10-Q 13 Nov 2025
Q4 2023 -$156M -$12.9M +$40.9M +76% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025
Q3 2023 -$197M -$67.4M -$11.2M -19.9% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 -$186M -$18.7M +$40.3M +68.4% 01 Apr 2023 30 Jun 2023 10-Q 13 Nov 2024
Q1 2023 -$226M -$57.1M -$2.95M -5.45% 01 Jan 2023 31 Mar 2023 10-Q 13 Nov 2024
Q4 2022 -$223M -$53.8M +$1.51M +2.72% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$225M -$56.2M -$13.2M -30.7% 01 Jul 2022 30 Sep 2022 10-Q/A 13 Nov 2023
Q2 2022 -$211M -$59M -$23.7M -67.1% 01 Apr 2022 30 Jun 2022 10-Q/A 13 Nov 2023
Q1 2022 -$188M -$54.1M -$31M -134% 01 Jan 2022 31 Mar 2022 10-Q/A 13 Nov 2023
Q4 2021 -$157M -$55.4M -$38.2M -222% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$119M -$43M -$35.7M -492% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$82.9M -$35.3M -$26.1M -284% 01 Apr 2021 30 Jun 2021 10-Q 14 Nov 2022
Q1 2021 -$56.8M -$23.1M -$19M -466% 01 Jan 2021 31 Mar 2021 10-Q 14 Nov 2022
Q4 2020 -$37.7M -$17.2M 01 Oct 2020 31 Dec 2020 10-K 07 Mar 2022
Q3 2020 -$7.26M 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$9.2M 01 Apr 2020 30 Jun 2020 10-Q 15 Nov 2021
Q1 2020 -$4.09M 01 Jan 2020 31 Mar 2020 10-Q 15 Nov 2021

Instil Bio, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$74.1M +$82M +52.5% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025
2023 -$156M +$67.1M +30.1% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025
2022 -$223M -$66.4M -42.3% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$157M -$119M -315% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$37.7M 01 Jan 2020 31 Dec 2020 10-K 07 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.